Ajanta Pharma Share Price Target 2025 to 2030: Hello Friends, today we are going to give you complete information about Ajanta Pharma Share Price. If you want to know what is the future of Ajanta Pharma Share Price and what is its target? So we will give you complete information about Ajanta Pharma Share in detail.
Ajanta Pharma Share Price Target
If we talk about Ajanta Pharma Share Price Target, then its share is going to increase in the coming 10 years. Talking about its performance, this stock has performed well in the last few months and has given money to all the investors. Investors of Ajanta Pharma Share are increasing very fast and all the investors are also investing funds. If you are a long-term investor then this share will give you good returns.
Ajanta Pharma Company Details
Ajanta Pharma Limited is a specialist pharmaceutical firm headquartered in India. The company offers a wide variety of specialty branded generic medications that address a wide spectrum of acute and chronic medical conditions. The business manufactures and distributes both generic and branded pharmaceutical items.
Cardiology, anti-diabetes, ophthalmology, dermatology, antibiotic, anti-malarial, pain, respiratory, gynecological, pediatric, and general health medications are only a few of its many therapeutic areas. Its branded generics business is located in Africa, Asia, and India. Additionally, it operates in two verticals: institutional business in Africa and generics in the United States. Bimat (anti-glaucoma), Nepaflam (anti-inflammatory), Softdrops (lubricant), and Olopat (anti-allergic) are some of its ophthalmology products. MET XL, Atorfit CV, Antihypertensive Cinod, Rosutor Gold, Dapalex, and Vilatin are among the cardiology drugs offered by the company.
Fundamental Details
- P/E Ratio (TTM): 36.55
- EPS (TTM): 58.43
- Dividend Yield: 0.33%
- Market Cap: ₹26,893Cr
Financial Details
| 2019 | 2020 | 2021 | 2022 | 2023 | |
| Revenue | Rs. 2,076 Cr | Rs. 2,680 Cr | Rs. 2,916 Cr | Rs. 3,457 Cr | Rs. 3,841 Cr |
| Profit | Rs. 387 Cr | Rs. 468 Cr | Rs. 654 Cr | Rs. 713 Cr | Rs. 588 Cr |
| Net Worth | Rs. 2,245 Cr | Rs. 2,599 Cr | Rs. 2,996 Cr | Rs. 3,264 Cr | Rs. 3,388 Cr |
Ajanta Pharma Share Price Target 2025 to 2030
Ajanta Pharma Share Price Target 2025 ₹182.19, 2026 ₹224.30, 2027 ₹273.45, 2028 ₹333.37, 2029 ₹406.43, 2030 ₹495.49.
| Ajanta Pharma Share Price Target | Price |
| Ajanta Pharma Share Price Target 2025 | ₹2330.74 |
| Ajanta Pharma Share Price Target 2026 | ₹2460.45 |
| Ajanta Pharma Share Price Target 2027 | ₹2590.36 |
| Ajanta Pharma Share Price Target 2028 | ₹2715.58 |
| Ajanta Pharma Share Price Target 2029 | ₹2840.69 |
| Ajanta Pharma Share Price Target 2030 | ₹2970.47 |
Ajanta Pharma Share Price Target 2025
If we predict Ajanta Pharma Share for 2025, then looking at the growth of this share, the expectation is that this share will increase the money of all the investors and will give profit to all the investors. Looking at the market growth of this share, it is expected that this share will grow from Upto ₹2330.74 by the end of 2025. Ajanta Pharma Share Price Target for 2025 is ₹2330.74.
| Ajanta Pharma Share Price Target 2025 | ₹2330.74 |
Ajanta Pharma Share Price Target 2030
Talking about Ajanta Pharma Share, this share is on a bullish trend every year and the year ending of this share is with profit only. If we talk about 2030, then it is expected that this share will close upto ₹2970.47 this year. Looking at the bullish trend of this stock, it is expected that this year too it will add profit by making the money of all its investors profitable. Ajanta Pharma Share Price Target for 2030 is ₹2970.47.
| Ajanta Pharma Share Price Target 2030 | ₹2970.47 |
Also Read: Ahlada Engineers Share Price Target
Also Read: Agro Tech Foods Share Price Target
Also Read: Agro Phos India Share Price Target
Also Read: Agri-Tech (India) Share Price Target
| Disclaimer: This article is for informational purposes only and should not be considered investment advice. The price targets or predictions provided are generated by a custom algorithm using deep learning, which may change due to market fluctuations, volume shifts, and market cycles. It is strongly recommended not to base investments solely on the target price mentioned. |